• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MDT PUERTO RICO OPERATIONS CO SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MDT PUERTO RICO OPERATIONS CO SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE Back to Search Results
Model Number 8637-20
Device Problems Premature Elective Replacement Indicator (1483); Inappropriate or Unexpected Reset (2959)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 02/20/2017
Event Type  Injury  
Manufacturer Narrative
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Information was received from a healthcare provider regarding a patient receiving gablofen 300 mcg/ml at 127.04 mcg/day via an implantable pump.The indications for use were intractable spasticity and multiple sclerosis.The healthcare provide reported an non-critical alarm was occurring.The healthcare provider stated eri (elective replacement indicator) was occurring.It was noted that at the last refill on (b)(6) 2017 the eri (elective replacement indicator) was 16 months.Per the healthcare provider the alarm was unexpected.The healthcare provider stated that the patient¿s managing healthcare provider was out of the country so the healthcare provider would be calling a surgeon to discuss scheduling a pump replacement as soon as possible.The healthcare provider also reported that they had aspirated the catheter to ensure it was patent prior to scheduling the replacement.When programming the priming bolus the pump started to critically alarm and stated the pump was in safestate, reset occurred.It was recommended to replace the pump as soon as medically possible.The healthcare provider stated that the patient was scheduled for a consult with the surgeon next friday but they would try to move that up.There were no reported patient symptoms.
 
Manufacturer Narrative
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received on 06-mar-2017 and it was reported that the pump was replaced.
 
Manufacturer Narrative
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information received reported the troubleshooting included interrogating the pump and calling the manufacturer and the company representative.The actions and interventions were reported as eri alarm (b)(6) 2017, safe state and reset (b)(6) 2017.Per the healthcare provider the cause of the messages were battery performance issue, pump was implanted (b)(6) 2011.The issue was resolved.The itb (intrathecal baclofen ) pump was replaced (b)(6) 2017.
 
Manufacturer Narrative
Analysis results were not available at the time of this report.A follow-up report will be sent when analysis is completed.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received from a manufacturer representative regarding a patient who was receiving lioresal with a concentration of 500.0 mcg/ml at a daily dose of 3.04 mcg/day by minimum rate infusion via an implantable pump.Pump activity logs indicated that low battery resets occurred on (b)(6) 2017 at 12:41, 12:42, and 12:44.
 
Manufacturer Narrative
Analysis of the pump on 2017-apr-12 revealed high battery resistance.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNCHROMED II
Type of Device
PUMP, INFUSION, IMPLANTED, PROGRAMMABLE
Manufacturer (Section D)
MDT PUERTO RICO OPERATIONS CO
rd 31 km 24 hm 4
juncos PR 00777
Manufacturer (Section G)
MDT PUERTO RICO OPERATIONS CO
rd 31 km 24 hm 4
juncos PR 00777
Manufacturer Contact
lisa woodward clark
7000 central avenue ne rcw215
minneapolis, MN 55432
7635263920
MDR Report Key6356004
MDR Text Key68218561
Report Number3004209178-2017-04516
Device Sequence Number1
Product Code LKK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P860004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Nurse
Remedial Action Recall
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 05/05/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/28/2012
Device Model Number8637-20
Device Catalogue Number8637-20
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/20/2017
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/23/2017
Initial Date FDA Received02/24/2017
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Not provided
Not provided
04/12/2017
04/12/2017
Supplement Dates FDA Received03/07/2017
03/09/2017
03/23/2017
05/05/2017
10/02/2017
10/02/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/08/2011
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberZ-2276-2009 Z-3043-2011
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age49 YR
-
-